Dr. Scott M. Rocklage is the managing partner at 5 AM Venture Management LLC. He has held this position since 2004. He joined the company as a partner in 2003. Dr. Rocklage has a wealth of experience in healthcare management. He served in several organizations in management positions. He served at the EPIRUS Biopharmaceuticals, Inc. since May 6th to 2016 to May 11th, 2016 as the acting Chief Executive Officer. He assumed the office of the full Chief Executive Officer from May 11th, 2016. Read more: Scott Rocklage | LinkedIn
He doubled this position with being the president at the Amersham Health. Dr. Rocklage has also been a Director of Rennovia Inc. since 2013 to date as well as the chairman of the board of both Cidara therapeutical Inc., and Novira Therapeutics Inc. Scott is based at the Boston M.A Office.
Scott Rocklage attained his Ph.D. in chemistry from Massachusetts Institute of Technology. He has extensive experience in health care, scientific background, and also has tactical leadership track records. He has been part of inventing and co-inventing of over 30 U.S. based patents. He also has over 100 peer-reviewed articles that have been published.
He has the approval of numerous drugs by food as well as drug administrations. The one thing that has made him a productive entrepreneur is that he is organized and known how to manage his time, prioritize agendas, and follow through with his calendaring.
Rocklage work is based in life science. The 5 AM is a seed and early-stage venture whose agenda is the building of the next generation companies that will mainly focus on life sciences. He works with entrepreneurs from various fields like physicians, scientist, or business innovators by assisting the shape their ideas to potential drugs that can be used in the treatment of unmet medical needs.
One of the things that excite him is the ability to target a specific mutation or a particular genotype so as to be able to cure cancer in unique ways. Using this method has led to many lives being extended and other even being saved. The treatment will continue to be developed in the future which means that more lives will be saved.